Combination of Interleukin-27 and MicroRNA for Enhancing Expression of Anti-Inflammatory and Proosteogenic Genes
Open Access
Abstract
Remission of inflammation has become an achievable goal in inflammatory or rheumatoid arthritis (RA); however, bone erosion continues in many patients. Interleukin- (IL-) 27 regulates immune and bone cell balance and also suppresses activities of several inflammatory cell types in RA. Despite its promise, challenges to clinical translation of IL-27 have been its partial effects in vivo. Due to their ability to modulate plasticity of bone and immune cell differentiation, we examined the potential for several microRNA (miR) candidates in enhancing the effects of IL-27. Using differentiation, luciferase, and real time quantitative PCR assays, we show that IL-27 promotes osteoblast differentiation, reduces expression of osteoblast inhibitory genes, and reduces osteoclast differentiation, and results suggest a potential coordination with TGF/BMP/SMAD and JAK/STAT pathways. We selected miRNA regulators of these and related pathways to examine whether the effects of IL-27 could be augmented for therapeutic applications. miR-29b and miR-21 augmented IL-27 proosteogenic while downregulating osteoclastogenic signals and also worked to reduce inflammatory signaling in activated macrophages, while miR-21 and miR-20b worked with IL-27 to reduce inflammatory gene expression in fibroblasts and T cells. It appears that several miRNAs can be utilized to enhance IL-27’s impact on modulating osteogenesis and reducing proinflammatory signaling.
Keywords
Funding Information
- National Institutes of Health (R21CA179699, R01CA196947)
- National Institutes of Health (R21CA179699, R01CA196947)
- Purdue University (R21CA179699, R01CA196947)
This publication has 33 references indexed in Scilit:
- [Inhibitory effect of miR-20b on airway inflammation in asthmatic mice].2015
- Anti-inflammatory effects of miR-21 in the macrophage response to peritonitisJournal of Leukocyte Biology, 2015
- Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertensionClinical Science, 2014
- Possible roles of IL-12-family cytokines in rheumatoid arthritisNature Reviews Rheumatology, 2012
- Interleukin‐27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitroJournal of Cellular Physiology, 2012
- Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in MacrophagesThe Journal of Immunology, 2010
- Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signalingArthritis & Rheumatism, 2010
- Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous systemNature Immunology, 2006
- Osteoclast differentiation and activationNature, 2003
- IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T CellsImmunity, 2002